Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel. more
Time Frame | EVGN | Sector | S&P500 |
---|---|---|---|
1-Week Return | -13.16% | -3.72% | -0.05% |
1-Month Return | -21.43% | -1.85% | 2.75% |
3-Month Return | -56% | -11.4% | 7.4% |
6-Month Return | -79.55% | -4.41% | 10.47% |
1-Year Return | -80.3% | 4.13% | 27.57% |
3-Year Return | -92.75% | 0.3% | 29.56% |
5-Year Return | -90.83% | 36.62% | 89.3% |
10-Year Return | -98.7% | 106.81% | 206.09% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 753.00K | 1.04M | 930.00K | 1.68M | 5.64M | [{"date":"2019-12-31","value":13.35,"profit":true},{"date":"2020-12-31","value":18.44,"profit":true},{"date":"2021-12-31","value":16.49,"profit":true},{"date":"2022-12-31","value":29.7,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 334.00K | 574.00K | 767.00K | 909.00K | 4.24M | [{"date":"2019-12-31","value":7.88,"profit":true},{"date":"2020-12-31","value":13.53,"profit":true},{"date":"2021-12-31","value":18.09,"profit":true},{"date":"2022-12-31","value":21.43,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 419.00K | 466.00K | 163.00K | 766.00K | 1.40M | [{"date":"2019-12-31","value":29.95,"profit":true},{"date":"2020-12-31","value":33.31,"profit":true},{"date":"2021-12-31","value":11.65,"profit":true},{"date":"2022-12-31","value":54.75,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 55.64% | 44.81% | 17.53% | 45.73% | 24.80% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":80.53,"profit":true},{"date":"2021-12-31","value":31.5,"profit":true},{"date":"2022-12-31","value":82.19,"profit":true},{"date":"2023-12-31","value":44.58,"profit":true}] |
Operating Expenses | 21.59M | 25.28M | 31.12M | 27.71M | 27.79M | [{"date":"2019-12-31","value":69.37,"profit":true},{"date":"2020-12-31","value":81.24,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":89.04,"profit":true},{"date":"2023-12-31","value":89.31,"profit":true}] |
Operating Income | (21.17M) | (24.81M) | (30.95M) | (26.94M) | (26.39M) | [{"date":"2019-12-31","value":-2116600000,"profit":false},{"date":"2020-12-31","value":-2481400000,"profit":false},{"date":"2021-12-31","value":-3095300000,"profit":false},{"date":"2022-12-31","value":-2694100000,"profit":false},{"date":"2023-12-31","value":-2639100000,"profit":false}] |
Total Non-Operating Income/Expense | 2.48M | (2.72M) | 1.04M | (2.13M) | 3.22M | [{"date":"2019-12-31","value":77.02,"profit":true},{"date":"2020-12-31","value":-84.47,"profit":false},{"date":"2021-12-31","value":32.36,"profit":true},{"date":"2022-12-31","value":-66.02,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (19.09M) | (26.17M) | (30.43M) | (29.75M) | (25.99M) | [{"date":"2019-12-31","value":-1909100000,"profit":false},{"date":"2020-12-31","value":-2617400000,"profit":false},{"date":"2021-12-31","value":-3043200000,"profit":false},{"date":"2022-12-31","value":-2975400000,"profit":false},{"date":"2023-12-31","value":-2598700000,"profit":false}] |
Income Taxes | 24.00K | 32.00K | 13.00K | 90.00K | (33.00K) | [{"date":"2019-12-31","value":26.67,"profit":true},{"date":"2020-12-31","value":35.56,"profit":true},{"date":"2021-12-31","value":14.44,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-36.67,"profit":false}] |
Income After Taxes | (19.11M) | (26.21M) | (30.45M) | (29.84M) | (25.95M) | [{"date":"2019-12-31","value":-1911500000,"profit":false},{"date":"2020-12-31","value":-2620600000,"profit":false},{"date":"2021-12-31","value":-3044500000,"profit":false},{"date":"2022-12-31","value":-2984400000,"profit":false},{"date":"2023-12-31","value":-2595400000,"profit":false}] |
Income From Continuous Operations | (19.11M) | (26.21M) | (30.45M) | (29.84M) | (22.44M) | [{"date":"2019-12-31","value":-1911500000,"profit":false},{"date":"2020-12-31","value":-2620600000,"profit":false},{"date":"2021-12-31","value":-3044500000,"profit":false},{"date":"2022-12-31","value":-2984400000,"profit":false},{"date":"2023-12-31","value":-2243800000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (19.11M) | (23.37M) | (27.79M) | (26.64M) | (23.88M) | [{"date":"2019-12-31","value":-1911500000,"profit":false},{"date":"2020-12-31","value":-2337400000,"profit":false},{"date":"2021-12-31","value":-2779300000,"profit":false},{"date":"2022-12-31","value":-2663800000,"profit":false},{"date":"2023-12-31","value":-2387900000,"profit":false}] |
EPS (Diluted) | (0.71) | (0.82) | (0.69) | (0.64) | (0.53) | [{"date":"2019-12-31","value":-71,"profit":false},{"date":"2020-12-31","value":-82,"profit":false},{"date":"2021-12-31","value":-69,"profit":false},{"date":"2022-12-31","value":-64,"profit":false},{"date":"2023-12-31","value":-53,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
EVGN | |
---|---|
Cash Ratio | 0.86 |
Current Ratio | 1.09 |
Quick Ratio | 1.03 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
EVGN | |
---|---|
ROA (LTM) | -28.46% |
ROE (LTM) | -82.37% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
EVGN | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.69 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -0.11 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
EVGN | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 1.03 |
P/B | 4.71 |
Price/FCF | NM |
EV/R | 0.11 |
EV/Ebitda | NM |
PEG | NM |
Evogene (EVGN) share price today is $1.32
Yes, Indians can buy shares of Evogene (EVGN) on Vested. To buy Evogene from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in EVGN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Evogene (EVGN) via the Vested app. You can start investing in Evogene (EVGN) with a minimum investment of $1.
You can invest in shares of Evogene (EVGN) via Vested in three simple steps:
The 52-week high price of Evogene (EVGN) is $10.4. The 52-week low price of Evogene (EVGN) is $1.26.
The price-to-earnings (P/E) ratio of Evogene (EVGN) is
The price-to-book (P/B) ratio of Evogene (EVGN) is 4.71
The dividend yield of Evogene (EVGN) is 0.00%
The market capitalization of Evogene (EVGN) is $9.76M
The stock symbol (or ticker) of Evogene is EVGN